DOI:
10.1055/s-00000028
International Journal of Sports Medicine
LinksClose Window
References
Ruderman N, Prentki M.
AMP kinase and malonyl-CoA: targets for therapy of the metabolic syndrome.
Nat Rev Drug Discov 2004;
3: 340-351
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.